Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1982 Apr;79(7):2365-9.
doi: 10.1073/pnas.79.7.2365.

Long-term human cytolytic T-cell lines allospecific for HLA-DR6 antigen are OKT4+

Long-term human cytolytic T-cell lines allospecific for HLA-DR6 antigen are OKT4+

A M Krensky et al. Proc Natl Acad Sci U S A. 1982 Apr.

Abstract

Human allospecific cytotoxic T lymphocyte lines were established by weekly stimulation of peripheral blood lymphocytes with allogeneic Epstein-Barr virus-transformed lymphoblastoid cell lines in the presence of interleukin 2. The cytotoxic T lymphocyte lines were stimulated by either JY (which expresses HLA-A,B and -DR) or Daudi (which expresses HLA-DR but not -A,B antigens). Specificity of the effector cell lines was determined by antibody blocking and by patterns of cytolysis against a panel of target cell lines. The phenotype of the effector cells was identified by both negative (antibody and complement lysis) and positive (fluorescence-activated cell sorter) selection. The anti-JY lines only recognized targets bearing HLA-A2, B7 antigens and were composed exclusively of OKT4-8+ effector cells. The anti-Daudi lines, on the other hand, specifically recognized targets bearing DR6 and eventually contained only OKT4+8- cells. Thus, stimulation by Daudi cells can result in the generation of OKT4+ CTL lines that are allospecific for DR6 antigen.

PubMed Disclaimer

References

    1. Rev Sci Instrum. 1972 Mar;43(3):404-9 - PubMed
    1. Lancet. 1973 Mar 17;1(7803):573-6 - PubMed
    1. Eur J Immunol. 1974 May;4(5):378-87 - PubMed
    1. J Exp Med. 1975 Jun 1;141(6):1390-9 - PubMed
    1. J Virol. 1975 May;15(5):1065-72 - PubMed

Publication types

Substances